Illumina

Senior Manager, Informatics Sales Specialists , US

California Twp, Michigan, United States

Apply now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Genomics, BioinformaticsIndustries

Requirements

Candidates should possess a Bachelor’s degree and possess at least 10 years of experience in sales, with a strong focus on informatics sales or a related field. Demonstrated leadership experience managing sales teams is essential, along with a deep understanding of bioinformatics products and services.

Responsibilities

As the Senior Manager, Informatics Sales Specialists, you will develop and implement sales strategies to meet revenue quotas, lead and manage a team of Informatics Sales Specialists, ensure customer satisfaction, monitor market trends, establish territory quotas, control expenses, and provide feedback and development plans to the team. You will also be responsible for ensuring Illumina’s values are followed by all staff and utilizing sales analytics tools effectively.

Skills

Sales

Genomics

Bioinformatics

Leadership

Team Management

Sales Strategies

Market Trends

Communication

Interpersonal Skills

Customer Relationship Management

Data Analysis

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free